+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Approval"

From
From
Global Orphan Drugs Market 2023-2027 - Product Thumbnail Image

Global Orphan Drugs Market 2023-2027

  • Report
  • March 2023
  • 171 Pages
  • Global
From
From
From
Orexin Receptor Type 1 - Drugs In Development, 2021 - Product Thumbnail Image

Orexin Receptor Type 1 - Drugs In Development, 2021

  • Report
  • July 2021
  • 85 Pages
  • Global
From
The US Drug Approval Trends and Yearbook 2008/2009 - Product Thumbnail Image

The US Drug Approval Trends and Yearbook 2008/2009

  • Book
  • July 2008
  • 200 Pages
  • United States
New Drug Approval in the European Union - Product Thumbnail Image

New Drug Approval in the European Union

  • Book
  • June 2002
  • 356 Pages
  • Europe
Loading Indicator

The Drug Approval market is a key component of the Drug Discovery process. It involves the evaluation of a drug's safety and efficacy by regulatory authorities, such as the US Food and Drug Administration (FDA). This process is essential for the approval of a drug for commercial use. It involves the submission of a New Drug Application (NDA) to the FDA, which includes data from pre-clinical and clinical trials. The FDA then reviews the data and makes a decision on whether to approve the drug. The Drug Approval market is highly competitive, with many companies vying for approval of their drugs. Companies in the Drug Approval market include pharmaceutical companies such as Pfizer, Merck, and GlaxoSmithKline, as well as biotechnology companies such as Amgen and Genentech. Other companies involved in the market include contract research organizations (CROs) and clinical research organizations (CROs). Show Less Read more